Flashpoint Therapeutics Scientific Founder, Chad Mirkin, Receives 2024 Kavli Prize for Groundbreaking Work on Spherical Nucleic Acids

Seaking Alpha

Seeking Alpha / Seaking Alpha 1 Views

Award Marks Milestone in Flashpoint's Journey to Translate Cutting Edge Science into Breakthrough Therapies CHICAGO, Sept. 19, 2024 /PRNewswire/ -- Flashpoint Therapeutics proudly announces that its scientific founder, Professor Chad A. Mirkin, has been awarded the 2024 Kavli Prize in...

Comments